About the Journal
Inflammatory Bowel Diseases® supports the mission of the Crohn's & Colitis Foundation by publishing research that will improve the quality of life of patients and bring us closer to cures. Each issue contains original basic science, translational, and clinical research regarding pathogenesis, epidemiology, evaluation, and treatment of inflammatory bowel disease (IBD) that will lead to advancements in overall clinical care.
Articles published in Inflammatory Bowel Diseases® are from clinicians and researchers around the world and highlight unique and important issues in adult and pediatric IBD. We seek to publish novel and innovative research that will have a positive impact on the lives of children and adults with IBD. The journal does not accept case reports.
Inflammatory Bowel Diseases® is the official journal of the Crohn's & Colitis Foundation. We invite you to read more about the Foundation's mission and core values.
Becoming digital-only
Starting in January 2024, Inflammatory Bowel Diseases® will be transitioning to a digital-only format, shrinking our footprint while providing an even more immersive and immediate reading experience for you.
Going digital demonstrates our commitment to top-notch, cutting-edge research while allowing us to enhance the content, interactivity, and accessibility of our journal, ensuring you have seamless access to the latest IBD updates.
Embracing the digital frontier means readers will enjoy:
- Instant Access: No more waiting for your journal to arrive in the mail. Readers are guaranteed access to the most current versions of all articles at all times, and immediate access to the most recently published content via the advance articles feature.
- Enhanced Interactivity: The Oxford Academic platform allows you to dive deeper into research with digital content components, usage information, reference linking and other vital tools that a printed issue cannot provide.
- Reader-Centric Innovation: This transition enables us to build a complete picture of reader engagement with our articles and other digital elements, which will inform future content to improve your experience.
We trust this transition will allow us to serve you better and keep you squarely at the forefront of advancements in IBD.
To get notified as soon as articles go online, make sure you are signed up for the journal's e-alerts.
